@article{9b4cfb7d7c764d1d88cf1797939d2e35,
title = "Antiemesis, version 2.2017 featured updates to the NCCN guidelines",
abstract = "The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Antiemesis address all aspects of management for chemotherapy-induced nausea and vomiting. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for Antiemesis, specifically those regarding carboplatin, granisetron, and olanzapine.",
author = "Berger, {Michael J.} and Ettinger, {David S.} and Jonathan Aston and Sally Barbour and Jason Bergsbaken and Bierman, {Philip J.} and Debra Brandt and Dolan, {Dawn E.} and Georgiana Ellis and Kim, {Eun Jeong} and Steve Kirkegaard and Kloth, {Dwight D.} and Ruth Lagman and Dean Lim and Charles Loprinzi and Ma, {Cynthia X.} and Victoria Maurer and Michaud, {Laura Boehnke} and Nabell, {Lisle M.} and Kim Noonan and Eric Roeland and Rugo, {Hope S.} and Schwartzberg, {Lee S.} and Bridget Scullion and John Timoney and Barbara Todaro and Urba, {Susan G.} and Shead, {Dorothy A.} and Miranda Hughes",
note = "Funding Information: This activity is supported by educational grants from Astellas, AstraZeneca, Celldex Therapeutics, Clovis Oncology, Genomic Health, Inc., Kyowa Hakko Kirin, Jazz Pharmaceuticals, Novartis Pharmaceuticals Corporation, and NOVOCURE. This activity is supported by an independent educational grant from Merck Co., Inc. Publisher Copyright: {\textcopyright} JNCCN-Journal of the National Comprehensive Cancer Network.",
year = "2017",
month = jul,
day = "1",
doi = "10.6004/jnccn.2017.0117",
language = "English (US)",
volume = "15",
pages = "883--893",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "7",
}